- Home
- VIGL vs ACNT Comparison
VIGL vs ACNT Comparison
Compare VIGL & ACNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIGL
- ACNT
- Stock Information
- Founded
- VIGL 2020
- ACNT 1945
- Country
- VIGL United States
- ACNT United States
- Employees
- VIGL N/A
- ACNT N/A
- Industry
- VIGL Biotechnology: Pharmaceutical Preparations
- ACNT Steel/Iron Ore
- Sector
- VIGL Health Care
- ACNT Industrials
- Exchange
- VIGL Nasdaq
- ACNT Nasdaq
- Market Cap
- VIGL 95.2M
- ACNT 109.8M
- IPO Year
- VIGL 2022
- ACNT N/A
- Fundamental
- Price
- VIGL $2.08
- ACNT $11.06
- Analyst Decision
- VIGL Strong Buy
- ACNT
- Analyst Count
- VIGL 5
- ACNT 0
- Target Price
- VIGL $19.75
- ACNT N/A
- AVG Volume (30 Days)
- VIGL 331.7K
- ACNT 32.1K
- Earning Date
- VIGL 11-07-2024
- ACNT 11-12-2024
- Dividend Yield
- VIGL N/A
- ACNT N/A
- EPS Growth
- VIGL N/A
- ACNT N/A
- EPS
- VIGL N/A
- ACNT N/A
- Revenue
- VIGL N/A
- ACNT $178,417,000.00
- Revenue This Year
- VIGL N/A
- ACNT $5.81
- Revenue Next Year
- VIGL N/A
- ACNT $6.79
- P/E Ratio
- VIGL N/A
- ACNT N/A
- Revenue Growth
- VIGL N/A
- ACNT 6.56
- 52 Week Low
- VIGL $1.49
- ACNT $8.16
- 52 Week High
- VIGL $6.06
- ACNT $12.38
- Technical
- Relative Strength Index (RSI)
- VIGL 55.12
- ACNT 45.37
- Support Level
- VIGL $1.79
- ACNT $11.06
- Resistance Level
- VIGL $2.02
- ACNT $11.33
- Average True Range (ATR)
- VIGL 0.16
- ACNT 0.23
- MACD
- VIGL 0.08
- ACNT -0.07
- Stochastic Oscillator
- VIGL 96.72
- ACNT 0.00
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.
About ACNT Ascent Industries Co.
Ascent Industries Co is engaged in the chemical and metal industry. The group operates into two reportable segments namely the Ascent Tubular Products and the Specialty Chemicals Segment. The Tubular Products segment serves markets through pipe and tube and customers in the appliance, architectural, automotive and commercial transportation, brewery, chemical, petrochemical and other industries. The Specialty Chemicals segment produces specialty products for the pulp and paper, coatings, adhesives, sealants and elastomers (CASE), textile, automotive, household and other industries. It manufactures welded pipe and tube, majorly from stainless steel, duplex, and nickel alloys. The company also produces specialty chemicals and dyes used in various end markets.